Format

Send to

Choose Destination
Oncoimmunology. 2012 Dec 1;1(9):1617-1619.

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

Author information

1
INSERM U1098; Unité Mixte de Recherche; Besançon, France ; Etablissement Français du Sang de Bourgogne Franche-Comté; Besançon, France ; Université de Franche-Comté; Besançon, France.

Abstract

Insights into antitumor T-cell responses may help the development of more efficient treatments for lung cancer. The interplay between preexisting antitumor CD4(+) T-cell responses and platinum-based chemotherapy is crucial to improve patient survival. Accumulating evidence confirms that selecting cancer patients in whom chemotherapy can activate an anticancer immune response would largely improve the success of novel therapeutic approaches.

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center